EMPO yields 500000.00% · ABBV yields 3.06%● Live data
📍 EMPO pulled ahead of the other in Year 1
Combined, EMPO + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EMPO + ABBV for your $10,000?
Empowered Products, Inc., together with its subsidiaries, manufactures, sells, and distributes personal care products principally in the United States, Europe, and Asia. It provides various products, including topical gels, lotions, and oils, which are designed to enhance a person's mental focus and to improve the bond of interpersonal relationships. The company sells 12 formulated skin lubricants under PINK for women and GUN OIL for men trademarks. It offers various products for men, such as GUN OIL Silicone, a silicone-based interactive lubricant; GUN OIL H2O, a water-based interactive lubricant; GUN OIL Force Recon, a combination water and silicone interactive lubricant; GUN OIL Gel, a gelatinous lubricant for men's personal toys; GUN OIL Stroke 29, a self-applied men's personal lubricant; GUN OIL Loaded, a silicone infused cream hybrid interactive lubricant; GUN OIL Jack Jelly, a self-applied men's personal lubricant in gelatinous form; and GUN OIL Shine, a personal toy cleaner. The company also provides products for women comprising PINK Silicone, an interactive lubricant with silicone vitamin E and aloe vera; PINK Water, a water-based interactive lubricant with vitamin E and aloe vera; Hot PINK, an exothermic massage lubricant; PINK Frolic, a women's personal toy lubricant; PINK Unity, a gelatinous hybrid lubricant with silicone and water; PINK Indulgence Crème, a hybrid cream interactive lubricant; and PINK Sparkle, a personal toy cleaner. Empowered Products, Inc. sells its products directly to retailers, as well as to consumers through its online Wellness Stores. The company is headquartered in Las Vegas, Nevada.
Full EMPO Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.